CRAP Continuous Improvement & Updates 3 — Questions and Answers
Question 1: A regulatory affairs professional is monitoring the Federal Register for rule changes. A final rule is published with a compliance date 18 months away. What is the FIRST step in an effective continuous improvement response?
- Wait 12 months before planning to allow for potential amendments
- Immediately perform a gap assessment to identify affected processes and products (Correct answer)
- File public comments requesting an extension
- Notify the sales team to adjust forecasts
Correct answer: Immediately perform a gap assessment to identify affected processes and products
Immediate gap assessment identifies all affected products, processes, and submissions so implementation planning can begin with adequate lead time.
Question 2: Which metric is MOST useful for evaluating the effectiveness of a regulatory affairs continuous improvement program over time?
- Number of SOPs in the quality system
- First-cycle approval rate for regulatory submissions (Correct answer)
- Total employee headcount in regulatory affairs
- Volume of published FDA guidance documents reviewed
Correct answer: First-cycle approval rate for regulatory submissions
First-cycle approval rate directly measures whether process improvements are producing higher-quality submissions that gain approval without requests for additional information.
Question 3: An FDA Warning Letter cites a company for failure to investigate consumer complaints that could indicate product adulteration. Under 21 CFR 211.198, what corrective action is most critical?
- Revise the complaint SOP to exclude minor complaints from investigation
- Establish a complaint trending and investigation system that triggers CAPA for potentially serious complaints (Correct answer)
- Transfer complaint handling to the marketing department
- Close all open complaints within 30 days regardless of investigation status
Correct answer: Establish a complaint trending and investigation system that triggers CAPA for potentially serious complaints
21 CFR 211.198 requires investigation of complaints that could indicate product failure, necessitating a robust system that identifies and investigates potentially serious complaints.
Question 4: In the context of ICH Q8, 'design space' primarily facilitates continuous improvement by:
- Eliminating the need for process validation
- Allowing operational flexibility within proven acceptable ranges without requiring regulatory submissions (Correct answer)
- Replacing stability testing with real-time release
- Reducing the number of required batch records
Correct answer: Allowing operational flexibility within proven acceptable ranges without requiring regulatory submissions
Movement within the approved design space is not considered a change requiring regulatory submission, enabling manufacturers to optimize processes without filing supplements.
Question 5: A company wants to implement a Corrective Action to address recurring Out-of-Specification (OOS) results. Before closing the CAPA, which documentation is REQUIRED under 21 CFR 211.192?
- Batch release certificate signed by QP
- Written record of the investigation including assignable cause and disposition decision (Correct answer)
- Annual product review entry for the OOS event
- FDA notification of OOS results within 15 days
Correct answer: Written record of the investigation including assignable cause and disposition decision
21 CFR 211.192 requires a written record of the laboratory investigation, including the cause of the OOS result if identified, and the disposition of the affected batch.
Question 6: A medical device manufacturer receives multiple MDRs citing the same failure mode within 6 months. Under 21 CFR Part 803, what continuous improvement obligation is triggered?
- Submit a 5-day report for each subsequent occurrence
- Analyze the trend and consider whether a remedial action or recall is necessary (Correct answer)
- Remove the device from the market pending FDA review
- File a 510(k) amendment describing the observed failure mode
Correct answer: Analyze the trend and consider whether a remedial action or recall is necessary
Recurring MDR events for the same failure mode require trend analysis to determine if a systemic corrective action, field safety corrective action, or recall is warranted.
Question 7: During a process validation review under FDA's 2011 Guidance on Process Validation, Stage 3 (Continued Process Verification) is BEST described as:
- A one-time study conducted before commercial manufacturing begins
- Ongoing assurance during routine production that the process remains in a state of control (Correct answer)
- Validation of cleaning procedures between product campaigns
- A retrospective review required only after an OOS event
Correct answer: Ongoing assurance during routine production that the process remains in a state of control
Stage 3 involves ongoing data collection and statistical analysis during routine production to ensure the validated process remains capable and in control.
CRAP Continuous Improvement & Updates 3
A regulatory affairs professional is monitoring the Federal Register for rule changes.
A final rule is published with a compliance date 18 months away.
What is the FIRST step in an effective continuous improvement response?